First-in-human study of SAR443765 in healthy participants and in asthmatic participants

Trial Identifier: PDY16622
Sponsor: Sanofi
Start Date: June 2022
Primary Completion Date: February 2023
Study Completion Date: February 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
GERMANY berlin, GERMANY
UNITED KINGDOM Belfast, UNITED KINGDOM, BT9 6AD